HLB bioStep Co.,Ltd. (KOSDAQ:A278650) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of its shares pursuant to a trust contract with Samsung Securities Co., Ltd. The purpose of the share repurchase is to enhance shareholder value and compensation for executive and employee performance. The repurchase program will expire on February 12, 2025.

As of February 7, 2024, the company had 784,523 shares within scope available for dividend and had no shares in treasury through other repurchase.